Insider · CIK 0001573072
David F Novack
coopresidentofficer
Files at DVAX (DYNAVAX TECHNOLOGIES CORP). First filing Mar 10, 2025, latest Mar 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $802k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | DYNAVAX TECHNOLOGIES CORP | $140k 10,000 shares | -55% | - | |
| 32Weak | DYNAVAX TECHNOLOGIES CORP | $190k 14,020 shares | -63% | - | |
| 37Weak | DYNAVAX TECHNOLOGIES CORP | $471k 32,764 shares | -60% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 24, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock10b5-1 | +10,000 | $6.81 | $68k | 18,078 | Mar 26, 2025 |
| Mar 24, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | SOpen-market sale Common Stock10b5-1 | -10,000 | $14.00 | $140k | 8,078 | Mar 26, 2025 |
| Mar 24, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | - | - | 186,528 | Mar 26, 2025 |
| Mar 18, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | SOpen-market sale Common Stock10b5-1 | -14,020 | $13.58 | $190k | 8,078 | Mar 20, 2025 |
| Mar 7, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | SOpen-market sale Common Stock10b5-1 | -32,764 | $14.39 | $471k | 22,098 | Mar 10, 2025 |
| Feb 18, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +22,620 | - | - | 65,527 | Feb 20, 2025 |
| Feb 18, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | FTax withholding Common Stock | -10,665 | $12.93 | $138k | 54,862 | Feb 20, 2025 |
| Feb 18, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -22,620 | - | - | 45,240 | Feb 20, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +26,500 | - | - | 54,156 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | FTax withholding Common Stock | -12,480 | $12.69 | $158k | 42,907 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Restricted Stock Unitderivative | +26,500 | - | - | 26,500 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -26,500 | - | - | 0 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Stock Option (Right to Buy)derivative | +93,000 | - | - | 93,000 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Restricted Stock Unitderivative | +56,364 | - | - | 56,364 | Feb 18, 2025 |
| Feb 10, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +8,833 | - | - | 32,174 | Feb 12, 2025 |
| Feb 10, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | FTax withholding Common Stock | -4,518 | $13.20 | $60k | 27,656 | Feb 12, 2025 |
| Feb 10, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -8,833 | - | - | 0 | Feb 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.